According to Humana's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 9.65291. At the end of 2022 the company had a P/E ratio of 23.1.
Year | P/E ratio | Change |
---|---|---|
2022 | 23.1 | 13.61% |
2021 | 20.4 | 26.31% |
2020 | 16.1 | -11.32% |
2019 | 18.2 | -22.36% |
2018 | 23.4 | 58.41% |
2017 | 14.8 | -70.24% |
2016 | 49.6 | 137.21% |
2015 | 20.9 | 8.11% |
2014 | 19.4 | 45.9% |
2013 | 13.3 | 46.15% |
2012 | 9.08 | -11.2% |
2011 | 10.2 | 22.51% |
2010 | 8.34 | 17.88% |
2009 | 7.08 | -26.32% |
2008 | 9.61 | -36.34% |
2007 | 15.1 | -18.96% |
2006 | 18.6 | -34.53% |
2005 | 28.4 | 67.66% |
2004 | 17.0 | 4.69% |
2003 | 16.2 | 37.75% |
2002 | 11.8 | -30.15% |
2001 | 16.8 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
14.9 | 54.07% | ๐บ๐ธ USA | |
20.8 | 115.61% | ๐บ๐ธ USA | |
12.9 | 33.98% | ๐บ๐ธ USA | |
18.1 | 87.10% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.